Trial record 1 of 1 for:    NCT01057810
Previous Study | Return to List | Next Study

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT01057810
First received: January 26, 2010
Last updated: September 2, 2015
Last verified: September 2015